POST-TRANSCRIPTIONAL REGULATION OF C-MYC MRNA
POST-TRANSCRIPTIONAL REGULATION OF C-MYC MRNA
批准号:
3306633
负责人:
William M Lee
金额:
$19.83万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 1996-04-30
关键词:
cell differentiation cell free system cell type cycloheximide frameshift mutation gene expression genetic regulatory element laboratory mouse messenger RNA myoblasts neoplastic transformation nucleic acid sequence oncogenes point mutation posttranscriptional RNA processing protein degradation transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Regulated C-myc gene expression is an important determinant of cell
proliferation and differentiation and averts neoplastic cell behavior.
Regulation usually occurs at the mRNA level, depends on the marked
instability of the mRNA for its rapidity and is frequently
post-transcriptional. Preliminary studies show that C2 murine myoblasts
express abundant c-myc mRNA and that the turnover of this mRNA is rapid and
depends on translation of C-terminal protein-coding sequences.
Differentiation of C2 cells is accompanied by a fall in c-myc mRNA levels,
which is due to accelerated turnover that also depends on translation of
C-terminal protein-coding sequences. The goal of this proposal is to
understand these post-transcriptional mechanisms regulating c-myc
expression. (I) Delineation of the structural determinant of translation-
dependent c-myc mRNA instability will be accomplished by testing myc
deletion and fusion mRNAs for induction by cycloheximide, which has been
shown to be due to mRNA stabilization by drug inhibition of translation and
is indicative of an unstable myc mRNA. Study of point and frame-shift
mutants will indicate if the nucleotide sequence or the encoded amino acid
sequence of this element is the instability determinant. A similar
approach will be used to delineate the structural element targeting c-myc
mRNA for regulation during C2 differentiation. This task may be simplified
by selecting only the most informative myc genes from the cycloheximide
studies for testing in the cumbersome C2 differentiation assay, since
preliminary studies indicate that the determinants of regulation and
instability may be the same. (II) Identification of these c-myc mRNA
structural determinants will be followed by characterization of their
significance. The current confusion resulting from the multiplicity of
putative destabilizing elements identified in c-myc mRNA to date will be
resolved by determining which candidate element actually influences the
steady-state level of c-myc mRNA by specifying its rate of turnover. The
prevalence of translation-dependent mechanisms for c-myc mRNA instability
and regulation during differentiation will be determined by examining their
usage in other cell types. If mRNAs other than c-myc are regulated by the
same mechanism during differentiation, they may share the myc mRNA
regulatory motif and be identifiable on this basis using appropriate search
or cloning strategies. (III) Knowledge gained about the cis-acting motifs
regulating c-myc mRNA levels will be used to characterize the transacting
factors involved. One approach will be to establish an in vitro system of
c-myc mRNA degradation that faithfully recapitulates in vivo events and can
be used to characterize and purify these factors. If a nucleotide sequence
forms the regulatory motif, identification of factors that bind this
sequence offers another approach. These studies promise to reveal factors
involved in the regulation of cellular mRNA turnover and to disclose the
molecular basis of post-transcriptional c-myc mRNA regulation, a key
element of the cell's normal response to growth and differentiation
stimuli.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:8141217
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:8730129
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
UT Southwestern: Clinical Site for the Drug-Induced Liver Injury Network
-
批准号:7591876
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:7932256
-
项目类别:
-
资助金额:$49.66万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
UT Southwestern: Clinical Site for the Drug-Induced Liver Injury Network
-
批准号:8330954
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
Hepatitis B Research Network Clinical Centers
-
批准号:9321421
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
UT Southwestern: Clinical Site for the Drug-Induced Liver Injury Network
-
批准号:7693775
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
UT Southwestern: Clinical Site for the Drug-Induced Liver Injury Network
-
批准号:8132960
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
UT Southwestern: Clinical Site for the Drug-Induced Liver Injury Network
-
批准号:7928729
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:7693832
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:8330285
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:8545814
-
项目类别:
-
资助金额:$24.44万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
-
批准号:7578376
-
项目类别:
-
资助金额:$16.19万
-
财政年份:2008
-
负责人:William M Lee
-
依托单位:
HALT-C TRIAL
-
批准号:7606312
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2007
-
负责人:William M Lee
-
依托单位:
HALT-C TRIAL
-
批准号:7377603
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2006
-
负责人:William M Lee
-
依托单位:
HALT-C TRIAL
-
批准号:7206002
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2005
-
负责人:William M Lee
-
依托单位:
HALT-C Trial
-
批准号:6975056
-
项目类别:
-
资助金额:$18.18万
-
财政年份:2004
-
负责人:William M Lee
-
依托单位:
Transgenic Mice as Models for Antivascular Therapy
-
批准号:6751617
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2003
-
负责人:William M Lee
-
依托单位:
Transgenic Mice as Models for Antivascular Therapy
-
批准号:6588184
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2003
-
负责人:William M Lee
-
依托单位:
Transgenic Mice as Models for Antivascular Therapy
-
批准号:6914443
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2003
-
负责人:William M Lee
-
依托单位:
海外基金